NeuExcell Therapeutics
Before NeuExcell, Ms. Xu was a researcher and lab manager at Penn State University. Prior to Penn State, Jie worked at a startup biotech company, Xenoport Inc., where she was part of the team building the research laboratory as one of the first employees. Jie’s research experience covers molecular biology, immunology, virology, and neurodevelopment.
Ms. Xu received her BS in Biochemistry from Peking University and MS in Cell Biology from Shanghai Institute of Biochemistry and Cell Biology.
This person is not in any offices
NeuExcell Therapeutics
1 followers
NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.